Difference between revisions of "User talk:Laner Verena/My sandbox"
From Bioblast
Laner Verena (talk | contribs) |
Laner Verena (talk | contribs) |
||
Line 8: | Line 8: | ||
* OROBOROS INSTRUMENTS gets HORIZON 2020 funding for two Marie Skłodowska-Curie-Projects: | * OROBOROS INSTRUMENTS gets HORIZON 2020 funding for two Marie Skłodowska-Curie-Projects: | ||
:::* '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. '''''[[TRACT|More info? | :::* '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. '''''[[TRACT|More info?]]''''' | ||
:::*'''TRANSMIT'''- Start in January 2017. '''''[[TRANSMIT|More info?]]''''' | :::*'''TRANSMIT'''- Start in January 2017. '''''[[TRANSMIT|More info?]]''''' |
Revision as of 13:30, 17 October 2016
- OROBOROS INSTRUMENTS gets HORIZON 2020 funding for two Marie Skłodowska-Curie-Projects:
- TRACT – Training in Cancer mechanisms and Therapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. More info?
- TRANSMIT- Start in January 2017. More info?
- COST Action CA15203 MITOEAGLE - official start by Nov 01, 2016. More info?